CHINOOK THERAPEUTICS INC's ticker is KDNY and the CUSIP is 16961L106. A total of 1 filers reported holding CHINOOK THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $899,873 | +91.6% | 23,422 | +15.5% | 0.00% | – |
| Q1 2023 | $469,598 | -7.5% | 20,285 | +4.7% | 0.00% | – |
| Q4 2022 | $507,677 | +50.7% | 19,377 | +13.1% | 0.00% | – |
| Q3 2022 | $336,835 | +9.4% | 17,133 | -2.7% | 0.00% | – |
| Q2 2022 | $307,999 | +11.7% | 17,610 | +4.5% | 0.00% | – |
| Q1 2022 | $275,813 | -16.7% | 16,859 | -16.9% | 0.00% | – |
| Q4 2021 | $331,000 | +31.3% | 20,295 | +2.8% | 0.00% | – |
| Q3 2021 | $252,000 | -5.3% | 19,736 | +4.9% | 0.00% | – |
| Q2 2021 | $266,000 | – | 18,817 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Parallel Advisors, LLC | 5 | $0 | 0.00% |